148
Views
11
CrossRef citations to date
0
Altmetric
Review

Alcoholism: protein expression profiles in a human hippocampal model

&
Pages 321-331 | Published online: 09 Jan 2014

References

  • Harper C, Matsumoto I. Ethanol and brain damage. Curr. Opin. Pharmacol.5(1), 73–78 (2005).
  • Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol. Clin. Exp. Res.24(5), 611–621 (2000).
  • Noël X, Van der Linden M, Schmidt N et al. Supervisory attentional system in nonamnesic alcoholic men. Arch. Gen. Psychiatry58(12), 1152–1158 (2001).
  • Bates ME, Bowden SC, Barry D. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp. Clin. Psychopharmacol.10(3), 193–212 (2002).
  • Bates ME, Barry D, Labouvie EW, Fals-Stewart W, Voelbel G, Buckman JF. Risk factors and neuropsychological recovery in clients with alcohol use disorders who were exposed to different treatments. J. Consult. Clin. Psychol.72(6), 1073–1080 (2004).
  • Jernigan TL, Butters N, DiTraglia G et al. Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol. Clin. Exp. Res.15(3), 418–427 (1991).
  • Pfefferbaum A, Lim KO, Zipursky RB et al. Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcohol. Clin. Exp. Res.16(6), 1078–1089 (1992).
  • Shear PK, Sullivan EV, Lane B, Pfefferbaum A. Mammillary body and cerebellar shrinkage in chronic alcoholics with and without amnesia. Alcohol. Clin. Exp. Res.20(8), 1489–1495 (1996).
  • Sullivan EV, Rosenbloom MJ, Serventi KL, Deshmukh A, Pfefferbaum A. Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia. Am. J. Psychiatry160(6), 1110–1116 (2003).
  • Sullivan EV. Compromised pontocerebellar and cerebellothalamocortical systems: speculations on their contributions to cognitive and motor impairment in nonamnesic alcoholism. Alcohol. Clin. Exp. Res.27(9), 1409–14019 (2003).
  • Harper CG, Kril JJ. Corpus callosal thickness in alcoholics. Br. J. Addict.83(5), 577–580 (1988).
  • Sullivan EV, Deshmukh A, Desmond JE, Lim KO, Pfefferbaum A. Cerebellar volume decline in normal aging, alcoholism, and Korsakoff’s syndrome: relation to ataxia. Neuropsychology14(3), 341–352 (2000).
  • Chanraud S, Martelli C, Delain F et al. Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacology32(2), 429–438 (2007).
  • Adams KM, Gilman S, Koeppe RA et al. Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcohol. Clin. Exp. Res.17(2), 205–210 (1993).
  • Dao-Castellana MH, Samson Y, Legault F et al. Frontal dysfunction in neurologically normal chronic alcoholic subjects: metabolic and neuropsychological findings. Psychol. Med.28(5), 1039–1048 (1998).
  • Noël X, Paternot J, Van der Linden M et al. Correlation between inhibition, working memory and delimited frontal area blood flow measure by 99mTc-Bicisate SPECT in alcohol-dependent patients. Alcohol Alcohol.36(6), 556–563 (2001).
  • Ryabinin AE. Role of hippocampus in alcohol-induced memory impairment: implications from behavioral and immediate early gene studies. Psychopharmacology (Berl.)139(1–2), 34–43 (1998).
  • Bowden SC, McCarter RJ. Spatial memory in alcohol-dependent subjects: using a push-button maze to test the principle of equiavailability. Brain Cogn.22(1), 51–62 (1993).
  • White AM, Matthews DB, Best PJ. Ethanol, memory, and hippocampal function: a review of recent findings. Hippocampus10(1), 88–93 (2000).
  • Bonthius DJ, Woodhouse J, Bonthius NE, Taggard DA, Lothman EW. Reduced seizure threshold and hippocampal cell loss in rats exposed to alcohol during the brain growth spurt. Alcohol. Clin. Exp. Res.25(1), 70–82 (2001).
  • Harding AJ, Wong A, Svoboda M, Kril JJ, Halliday GM. Chronic alcohol consumption does not cause hippocampal neuron loss in humans. Hippocampus7(1), 78–87 (1997).
  • Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A. Anterior hippocampal volume deficits in nonamnesic, aging chronic alcoholics. Alcohol. Clin. Exp. Res.19(1), 110–122 (1995).
  • Agartz I, Momenan R, Rawlings RR, Kerich MJ, Hommer DW. Hippocampal volume in patients with alcohol dependence. Arch. Gen. Psychiatry56(4), 356–363 (1999).
  • Laakso MP, Vaurio O, Savolainen L et al. A volumetric MRI study of the hippocampus in type 1 and 2 alcoholism. Behav. Brain Res.109(2), 177–186 (2000).
  • White AM, Matthews DB, Best PJ. Ethanol, memory, and hippocampal function: a review of recent findings. Hippocampus10(1), 88–93 (2000).
  • Melchior CL, Glasky AJ, Ritzmann RF. A low dose of ethanol impairs working memory in mice in a win-shift foraging paradigm. Alcohol10(6), 491–493 (1993).
  • Givens B. Low doses of ethanol impair spatial working memory and reduce hippocampal theta activity. Alcohol. Clin. Exp. Res.19(3), 763–767 (1995).
  • Ordy JM, Thomas GJ, Volpe BT, Dunlap WP, Colombo PM. An animal model of human-type memory loss based on aging, lesion, forebrain ischemia, and drug studies with the rat. Neurobiol. Aging9(5–6), 667–683 (1988).
  • Cadete-Leite A, Tavares MA, Uylings HB, Paula-Barbosa M. Granule cell loss and dendritic regrowth in the hippocampal dentate gyrus of the rat after chronic alcohol consumption. Brain Res.473(1), 1–14 (1988).
  • Bengochea O, Gonzalo LM. Effect of chronic alcoholism on the human hippocampus. Histol. Histopathol.5(3), 349–357 (1990).
  • Korbo L. Glial cell loss in the hippocampus of alcoholics. Alcohol. Clin. Exp. Res.23(1), 164–168 (1999).
  • King MA, Hunter BE, Walker DW. Alterations and recovery of dendritic spine density in rat hippocampus following long-term ethanol ingestion. Brain Res.459(2), 381–385 (1988).
  • Durand D, Saint-Cyr JA, Gurevich N, Carlen PL. Ethanol-induced dendritic alterations in hippocampal granule cells. Brain Res.477(1–2), 373–377 (1989).
  • Herrera DG, Yague AG, Johnsen-Soriano S et al. Selective impairment of hippocampal neurogenesis by chronic alcoholism: protective effects of an antioxidant. Proc. Natl Acad. Sci. USA100(13), 7919–7924 (2003).
  • Tremwel MF, Hunter BE. Effects of chronic ethanol ingestion on long-term potentiation remain even after a prolonged recovery from ethanol exposure. Synapse17(2), 141–148 (1994).
  • Geuze E, Vermetten E, Bremner JD. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol. Psychiatry10(2), 160–184 (2005).
  • De Bellis MD, Clark DB, Beers SR et al. Hippocampal volume in adolescent-onsetalohol use disorders. Am. J. Psychiatry157(5), 737–744 (2000).
  • Miguel-Hidalgo JJ, Rajkowska G. Comparison of prefrontal cell pathology between depression and alcohol dependence. J. Psychiatr. Res.37(5), 411–420 (2003).
  • Cadete-Leite A, Alves MC, Tavares MA, Paula-Barbosa MM. Effects of chronic alcohol intake and withdrawal on the prefrontal neurons and synapses. Alcohol7(2), 145–152 (1990).
  • Walker DW, Barnes DE, Zornetzer SF, Hunter BE, Kubanis P. Neuronal loss in hippocampus induced by prolonged ethanol consumption in rats. Science209(4457), 711–713 (1980).
  • Bengoechea O, Gonzalo LM. Effects of alcoholization on the rat hippocampus. Neurosci. Lett.123(1), 112–114 (1991).
  • Adermark L, Olsson T, Hansson E. Ethanol acutely decreases astroglial gap junction permeability in primary cultures from defined brain regions. Neurochem. Int.45(7), 971–978 (2004).
  • Stephens DN, Ripley TL, Borlikova G et al. Repeated ethanol exposure and withdrawal impairs human fear conditioning and depresses long-term potentiation in rat amygdala and hippocampus. Biol. Psychiatry58(5), 392–400 (2005).
  • Ikegami Y, Goodenough S, Inoue Y, Dodd PR, Wilce PA, Matsumoto I. Increased TUNEL positive cells in human alcoholic brains. Neurosci. Lett.349(3), 201–205 (2003).
  • Okamoto H, Miki T, Lee KY et al. Oligodendrocyte myelin glycoprotein (OMgp) in rat hippocampus is depleted by chronic ethanol consumption. Neurosci. Lett.406(1–2), 76–80 (2006).
  • Coyle JT, Schwarcz R. Mind glue: implications of glial cell biology for psychiatry. Arch. Gen. Psychiatry57(1), 90–93 (2000).
  • Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos. Trans. R. Soc. Lond. B Biol. Sci.354(1387), 1155–1163 (1999).
  • Alexander-Kaufman K, Cordwell S, Harper C, Matsumoto I. A proteome analysis of the dorsolateral prefrontal cortex in human alcoholic patients. Proteomics Clin. App.1(1), 62–72 (2007).
  • Alexander-Kaufman K, Harper C, Wilce P, and Matsumoto I. The Cerebellar vermis proteome of chronic alcoholics. Alcohol. Clin. Exp. Res.31(8), 1286–1296 (2007).
  • Alexander-Kaufman K, James G, Sheedy D, Harper C, Matsumoto I. Differential protein expression in the prefrontal white matter of human alcoholics: a proteomics study. Mol. Psychiatry11(1), 56–65 (2006).
  • Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics6(11), 3414–3425 (2006).
  • Choudhary J, Grant SG. Proteomics in postgenomic neuroscience: the end of the beginning. Nat. Neurosci.7(5), 440–445 (2004).
  • Clark D, Dedova I, Cordwell S, Matsumoto I. A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol. Psychiatry11(5), 459–470, 423 (2006).
  • Clark D, Dedova I, Cordwell S, Matsumoto I. Altered proteins of the anterior cingulate cortex white matter proteome in schizophrenia. Proteomics Clin. App.1(2), 157–166 (2007).
  • Iwazaki T, McGregor IS, Matsumoto I. Protein expression profile in the striatum of acute methamphetamine-treated rats. Brain Res.1097(1), 19–25 (2006).
  • Iwazaki T, McGregor IS, Matsumoto I. Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitsation. Proteomics7, 1131–1139 (2007).
  • Kashem MA, James G, Harper C, Wilce P, Matsumoto I. Differential protein expression in the corpus callosum (splenium) of human alcoholics: a proteomics study. Neurochem. Int.50, 450–459 (2007).
  • Matsuda-Matsumoto H, Iwazaki T, Kashem MA, Harper C, Matsumoto I. Differential protein expression profiles in the hippocampus of human alcoholics. Neurochem. Int.51, 370–376, (2007).
  • Mei J, Kolbin D, Kao HT, Porton B. Protein expression profiling of postmortem brain in schizophrenia. Schizophr. Res.84(2–3), 204–213 (2006).
  • Novikova SI, He F, Cutrufello NJ, Lidow MS. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Neurobiol. Dis.23(1), 61–76 (2006).
  • O’Brien E, Dedova I, Duffy L et al. Effects of chronic risperidone treatment on the striatal protein profiles in rats. Brain Res.1113(1), 24–32 (2006).
  • Tannu N, Mash DC, Hemby SE. Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol. Psychiatry12(1), 55–73 (2007).
  • Lewohl JM, Wang L, Miles MF, Zhang L, Dodd PR, Harris RA. Gene expression in human alcoholism: microarray analysis of frontal cortex. Alcohol Clin. Exp. Res.24(12), 1873–1882 (2000).
  • Ferrer I, Fabregues I, Rairiz J, Galofre E. Decreased numbers of dendritic spines on cortical pyramidal neurons in human chronic alcoholism. Neurosci. Lett.69(1), 115–119 (1986).
  • Vallés S, Pitarch J, Renau-Piqueras J, Guerri C. Ethanol exposure affects glial fibrillary acidic protein gene expression and transcription during rat brain development. J. Neurochem.69(6), 2484–2493 (1997).
  • Pfefferbaum A, Sullivan EV. Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism. Neuroimage15(3), 708–718 (2002).
  • Harper C. The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J. Neuropathol. Exp. Neurol.57(2), 101–110 (1998).
  • Harper C, Kril J. If you drink your brain will shrink. Neuropathological considerations. Alcohol Alcohol. Suppl.1, 375–380 (1991).
  • Harper CG, Kril JJ, Holloway RL. Brain shrinkage in chronic alcoholics: a pathological study. Br. Med. J. (Clin. Res. Ed.)290(6467), 501–504 (1985).
  • Saito M, Smiley J, Toth R, Vadasz C. Microarray analysis of gene expression in rat hippocampus after chronic ethanol treatment. Neurochem. Res.27(10), 1221–1229 (2002).
  • Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol.19(3), 1720–1730 (1999).
  • Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis18(3–4), 533–537 (1997).
  • Lewohl JM, Van Dyk DD, Craft GE et al. The application of proteomics to the human alcoholic brain. Ann. NY Acad. Sci.1025, 14–26 (2004).
  • Phillips SC, Harper CG, Kril JJ. The contribution of Wernicke’s encephalopathy to alcohol-related cerebellar damage. Drug Alcohol Rev.9(1), 53–60 (1990).
  • Yang J W, Czech T, Lubec G. Proteomic profiling of human hippocampus. Electrophoresis25(7–8), 1169–1174 (2004).
  • Butterfield DA. Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer’s disease brain. A review. Free Radic. Res.36(12), 1307–1313 (2002).
  • Butterfield DA, Sultana R. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer’s disease and mild cognitive impairment: insights into the progression of this dementing disorder. J. Alzheimers Dis.12(1), 61–72 (2007).
  • Butterfield DA. Proteomics: a new approach to investigate oxidative stress in Alzheimer’s disease brain. Brain Res.1000, 1–7 (2004).
  • Edgar PF, Douglas JE, Cooper GJ, Dean B, Kydd R, Faull RL. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol. Psychiatry5, 85–90 (2000).
  • Costa E, Guidotti A. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci.49, 325–344 (1991).
  • Melov S, Schneider JA, Day BJ et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet.18, 159–163 (1998).
  • Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature376, 509–514 (1995).
  • Yaffe MB, Farr GW, Miklos D, Horwich AL, Sternlicht ML, Sternlicht H. TCP1 complex is a molecular chaperone in tubulin biogenesis. Nature358, 245–248 (1992).
  • Yang JW, Czech T, Felizardo M, Baumgartner C, Lubec G. Aberrant expression of cytoskeleton proteins in hippocampus from patients with mesial temporal lobe epilepsy. Amino Acids30(4), 477–493 (2006).
  • Suárez I, Bodega G, Fernández B, Glutamine synthetase in brain: effect of ammonia. Neurochem. Int.41(2–3), 123–142 (2002).
  • Girard G, Giguere JF, Butterworth RF. Region-selective reductions in activities of glutamine synthetase in rat brain following portacaval anastomosis. Metab. Brain Dis.8(4), 207–215 (1993).
  • Lavoie J, Giguere JF, Layrargues GP, Butterworth RF. Activities of neuronal and astrocytic marker enzymes in autopsied brain tissue from patients with hepatic encephalopathy. Metab. Brain Dis.2(4), 283–290 (1987).
  • Franke H, Kittner H, Berger P, Wirkner K, Schramek J. The reaction of astrocytes and neurons in the hippocampus of adult rats during chronic ethanol treatment and correlations to behavioral impairments. Alcohol14(5), 445–454 (1997).
  • Tagliaferro P, Vega MD, Evrard SG, Ramos AJ, Brusco A. Alcohol exposure during adulthood induces neuronal and astroglial alterations in the hippocampal CA-1 area. Ann. NY Acad. Sci.965, 334–342 (2002).
  • Montoliu C, Valles S, Renau-Piqueras J, Guerri C. Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: effect of chronic alcohol consumption. J. Neurochem.63(5), 1855–1862 (1994).
  • Agar E, Demir S, Amanvermez R, Bosnak M, Ayyildiz M, Celik C. The effects of ethanol consumption on the lipid peroxidation and glutathione levels in the right and left brains of rats. Int. J. Neurosci.113(12), 1643–1652 (2003).
  • Hemmer W, Wallimann T. Functional aspects of creatine kinase in brain. Dev. Neurosci.15(3–5), 249–260 (1993).
  • Kukita A, Mukai T, Miyata T, Hori K. The structure of brain-specific rat aldolase C mRNA and the evolution of aldolase isozyme genes. Eur. J. Biochem.171(3), 471–478 (1988).
  • Hamajima N, Tajima K, Morishita M et al. Patients’ expectations of information provided at cancer hospitals in Japan. Jpn. J. Clin. Oncol.26(5), 362–367 (1996).
  • Castegna A, Aksenov M, Thongboonkerd V et al. Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part II: dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71. J. Neurochem.82(6), 1524–1532 (2002).
  • Johnston-Wilson NL, Sims CD, Hofmann JP et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol. Psychiatry5(2), 142–149 (2000).
  • Weitzdoerfer R, Fountoulakis M, Lubec G, Aberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brain. J. Neural Transm. Suppl.61, 95–107 (2001).
  • Fountoulakis M. Application of proteomics technologies in the investigation of the brain. Mass Spectrom. Rev.23(4), 231–258 (2004).
  • O’Brien E, Dedova I, Duffy L, Cordwell S, Karl T, Matsumoto I. Effects of chronic risperidone treatment on the striatal protein profiles in rats. Brain Res.1113(1), 24–32 (2006).
  • Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis18(11), 2071–2077 (1997).
  • Griffin TJ, Han DK, Gygi SP et al. Toward a high-throughput approach to quantitative proteomic analysis: expression-dependent protein identification by mass spectrometry. J. Am. Soc. Mass Spectrom.12(12), 1238–1246 (2001).
  • Dosemeci A, Tao-Cheng J H, Vinade L, Jaffe H. Preparation of postsynaptic density fraction from hippocampal slices and proteomic analysis. Biochem. Biophys. Res. Commun.339(2), 687–694 (2006).
  • Qian HR, Huang S. Comparison of false discovery rate methods in identifying genes with differential expression. Genomics86(4), 495–503 (2005).
  • Emmert-Buck MR, Gillespie JW, Paweletz CP et al. An approach to proteomic analysis of human tumors. Mol. Carcinog.27(3), 158–165 (2000).
  • Molloy MP, Herbert BR, Walsh BJ et al. Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis19(5), 837–844 (1998).
  • Jung E, Heller M, Sanchez JC, Hochstrasser DF. Proteomics meets cell biology: the establishment of subcellular proteomes. Electrophoresis21(16), 3369–3377 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.